Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone
NCT00041626
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
INDUSTRY
Sponsor class
Conditions
Carcinoma, Squamous Cell
Interventions
GENETIC:
INGN 201
Sponsor
Introgen Therapeutics